STAR Market at 7: Building a Full-Cycle Financial Support System for Tech Enterprises

The STAR Market’s Seventh Anniversary: A Profound Transition from “Entry-Point Reform” to “Full-Cycle Financial Support”

On July 22, 2024, the Shanghai Stock Exchange’s Science and Technology Innovation Board (STAR Market) celebrates its seventh anniversary. This milestone coincides strategically with the Shanghai Stock Exchange’s recent release of the Notice on Further Strengthening Regulatory Oversight of Follow-on Financing by STAR Market–Listed Companies (hereinafter, the “Follow-on Financing Regulatory Notice”). At first glance, this represents a routine regulatory upgrade; in reality, however, it signals a pivotal shift in China’s capital market registration-based IPO reform—moving systematically beyond initial public offering (IPO) review at the “entry point” into the deeper domains of follow-on financing, M&A restructuring, equity incentives, and delisting or transfer mechanisms—the “financing” and “exit” endpoints. This is not merely a natural evolution of institutional frameworks, but an active, strategic elevation calibrated to the reconfiguration of global technological competition.

I. Shifting Regulatory Focus: From “Green-Lighting Listings” to “Safeguarding Sustainable Growth”—Solidifying Valuation Foundations for Hard Tech

When the STAR Market was launched, its core mission was to establish a “fast-track” listing channel for technology enterprises. Seven years on, over 570 hard-tech companies have listed on the STAR Market, spanning strategic national sectors such as integrated circuits, biopharmaceuticals, high-end equipment, and artificial intelligence. Yet practical experience reveals that “being eligible for listing” does not equate to “sustainable growth.” Some listed firms have subsequently experienced sharp earnings volatility, materially inaccurate earnings forecasts, or even financial fraud—seriously eroding investor confidence and undermining market consensus on valuing “hard-tech” assets.

The Follow-on Financing Regulatory Notice directly targets these critical vulnerabilities: it explicitly designates “financial fraud,” “materially inaccurate earnings forecasts,” and “inadequate disclosure of material risks” as red lines in follow-on financing reviews. It further mandates that sponsoring institutions conduct deep-dive, “end-to-end” due diligence on the technical feasibility, industrialization pathway, and market potential of funded projects. The underlying logic has undergone a fundamental transformation—regulators no longer focus solely on whether a company “meets listing criteria,” but increasingly on whether it can “generate authentic, sustainable value post-listing.” Especially in high-investment, long-cycle sectors—such as semiconductor equipment, AI large-model training chips, and clinical-stage innovative drugs—stable cash flows and credible profit expectations matter more for valuation anchoring than short-term revenue growth rates. By reinforcing information disclosure responsibilities and strengthening accountability among intermediaries, regulators are effectively building a “dynamic valuation infrastructure” for hard-tech enterprises—one grounded in technological barriers, R&D progress, and commercialization timelines.

II. Operationalizing the “Full-Life-Cycle” Concept: Reshaping Early-Stage Market Logic

The formal inclusion of “full-life-cycle financial services” in regulatory documents is no empty slogan. It heralds accelerated expansion of the policy toolkit:

• Pre-IPO Stage: Pilot programs may link “science-and-technology bonds” with warrant instruments, guiding bank wealth management products and insurance funds to engage earlier-stage hard-tech projects via hybrid “equity-debt” structures;
• Post-Listing Financing: Streamline small-scale, fast-track follow-on financing mechanisms—allowing qualified issuers to raise cumulative funds of up to 20% of net assets (capped at RMB 300 million) within 12 months, enabling “just-in-time, on-demand financing”;
• M&A & Integration: Relax restrictions on same-industry asset acquisitions via share issuance, supporting both horizontal industry consolidation and vertical integration around core technologies;
• Talent Incentives: Broaden the scope of Category II restricted stock units, permitting tighter linkage between equity incentives and R&D milestone achievements;
• Exit Channels: Deepen connectivity with the Beijing Stock Exchange (BSE) and Hong Kong Exchanges and Clearing (HKEX), explore streamlined transfer pathways from the STAR Market to HKEX’s Chapter 18C (for innovative technology companies), and study establishing a secondary fund (S-fund) trading platform to alleviate early-stage investment exit pressure.

This suite of measures is compelling the primary market to undertake profound introspection: the past “listing-arbitrage” model is no longer viable. Venture capital (VC) and private equity (PE) firms must evolve beyond assessing mere “technological sophistication,” instead cultivating a three-dimensional capability framework—comprising industry insight, commercialization forecasting acumen, and capital-market synergy expertise. For instance, in the AI chip sector, investors must rigorously assess efficiency gains in compatibility with domestic large-model training frameworks, customer adoption pace, and yield-ramp curves across fabrication runs—not just citation counts in academic papers. Capital patience is shifting from a “three-year IPO” mindset toward a “seven-year industrial cultivation” horizon—achieving genuine resonance with the intrinsic rhythms of hard-tech development.

III. Strategic Hedging: Building an Autonomous Capital “Gravity Field” Amidst AI Export Controls

Global technological competition has entered a new phase. The United States, in coordination with the European Union, continues tightening export controls on AI chips destined for China; ASML’s lithography tool supply to China faces increasing constraints; and cross-border data flows in biopharmaceuticals are subject to heightened scrutiny. Such external containment objectively accelerates China’s drive for technological self-reliance—and the responsiveness of capital markets directly determines the efficiency frontier of technological breakthroughs.

The STAR Market’s full-life-cycle support system is, in essence, a project to build a “policy-driven capital gravity field.” As overseas financing channels narrow, if the A-share market can deliver a complete closed loop—from angel investment through to M&A exits—it will significantly strengthen its appeal to world-class scientific entrepreneurs and returnee technical talent. Data show that in 2023, STAR Market semiconductor firms’ R&D expenditures averaged 18.7% of revenue—higher than the 12.3% average for comparable Nasdaq-listed peers; meanwhile, STAR Market biopharma firms saw annual average growth of 23% in their clinical pipeline assets—highlighting capital’s robust support for long-horizon innovation. This virtuous cycle linking technology → capital → industry constitutes the most effective, non-confrontational countermeasure against U.S.-EU technological decoupling—not through rivalry, but by winning the future with a more efficient, inclusive, and sustainable innovation ecosystem.

IV. Persistent Challenges: Institutional Coordination and Execution Precision Remain Crucial

Of course, translating vision into tangible outcomes still requires surmounting multiple hurdles. How can follow-on financing review standards balance “rigorous quality control” against “avoiding unintended harm”? Where lies the tolerance threshold for “strategic losses” in M&A transactions? How can equity incentive schemes be harmonized with state-owned asset performance evaluation systems? None of these questions can be resolved without cross-departmental coordination and fine-grained governance. Critically, vigilance against “policy arbitrage” is essential—preventing certain firms from repackaging speculative concepts under the “hard-tech” banner and exploiting relaxed follow-on financing policies for market manipulation or illicit benefit transfers. Only by embedding rigorous verification of technological authenticity into every stage of review—extending regulatory penetration down to laboratory data, production-line yield metrics, and customer contracts—can full-life-cycle support avoid becoming a new breeding ground for rent-seeking.

Seven years of dedicated cultivation have transformed the STAR Market from a tender sapling into a strategic pillar sustaining China’s technological self-reliance. As the fanfare of “opening the entry gate” fades into the distance, a profound transformation is unfolding across the financing and exit endpoints—a quiet revolution focused on how capital can precisely nourish the roots of innovation. This is not merely institutional self-renewal; it is a silent race for national technological competitiveness—where the winner will be the one who empowers innovators to focus undistracted on breakthroughs, and enables capital to accompany them rationally and steadfastly. That nation will hold the true first-mover advantage in the next wave of the global technological revolution.